St. Jude Medical Unveils Swift-Lock Anchor for Securing Neurostimulation During Pain Therapy

St. Paul, Minn.-based St. Jude Medical has announced FDA clearance of its Swift-Lock anchor, a new product designed to help physicians efficiently secure neurostimulation leads utilized in spinal cord stimulation therapy for the management of chronic pain, according to a St. Jude Medical news release.

Advertisement

Designed to reduce anchoring time and enhance procedural efficiency, the Swift-Lock anchor eliminates the need for sutures or medical adhesive typically required to secure the anchor to the lead and features an easy-to-use mechanical lock, according to the release.

The Swift-Lock anchor features include:

•    Intuitive locking mechanism that provides tactile and visual confirmation that the lead is locked;
•    Strong fixation to the lead to help mitigate the risk of migration;
•    Highly radiopaque material to provide easy fluoroscopic visualization; and
•    Simple twist lock mechanism allows for easy repositioning of the lead if needed.

Read the St. Jude Medical release on the Swift-Lock Anchor.

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.